Investor Presentaiton

HKAS 1.51 HK Listco Ltd Year ended 31 December 2023 Directors' Report The directors submit herewith their annual report together with the audited financial statements for the year ended 31 December 2023. HKAS 1.138(a) S390(1)(b), (3) S388(1)(a), (2) Principal place of business HK Listco Ltd ("the company") is a company incorporated and domiciled in Hong Kong and has its registered office and principal place of business at 11/F New View Building, 100 Smith Street, Central, Hong Kong5. Principal activities and business review The principal activities of the company and its subsidiaries ("the group") are the manufacturing and sale of electronic products, property development, property investment and carrying out construction activities for others. Further discussion and analysis of these activities as required by Schedule 5 to the Hong Kong Companies Ordinance, including a discussion of the principal risks and uncertainties facing the group and an indication of likely future developments in the group's business, can be found in the Management Discussion and Analysis set out on pages [•] to [•] of this Annual Report. That discussion forms part of this directors' report. HKAS 1.138(a) S388(1)(a), (2) Sch 5 5 HKAS 1 requires disclosure of the address of the registered office of the company (or its principal place of business, if different from its registered office), if this information is not disclosed elsewhere in information published with the financial statements. 6 7 The CO requires all companies incorporated under the CO to include a "business review" in accordance with Schedule 5 to the CO in their directors' report, unless they are specifically exempted under section 388 of the CO. Paragraph 28 of Appendix 16 to the MBL RS requires all listed entities, whether or not they are incorporated under the CO, to comply with Schedule 5, consistent with the SEHK's level playing field principle. This means that overseas issuers listed on the Stock Exchange of Hong Kong have also been required to include a business review in their directors' report. At the invitation of the Companies Registry, the HKICPA has issued Accounting Bulletin 5 to provide guidance on the preparation and presentation of the business review. Our publication "A practical guide to the business review (May 2015)" provides further guidance applicable to listed companies. Our business review disclosure checklist, which helps listed companies ensure that the minimum requirements of Schedule 5 and the MBLRs are met and includes checkpoints to cover the guidance in Accounting Bulletin 5, can be obtained from your usual KPMG contact. Section 388 and Schedule 5 to the CO requires the business review to be included in the directors' report. According to the response to Q15/Question A8 in the HKICPA's Q&A series on the CO (in the sub-section "Part A Directors' report" under the category "other than those relating to transition from the predecessor Ordinance (Cap. 32)"), this requirement can be met by including a cross reference in the directors' report to where this review is located if it is included elsewhere in the annual report. For example, given the similarities between the requirements of Schedule 5 and paragraphs 32 and 52 of Appendix 16 to the MBLRS, the requirements of Schedule 5 can be met by including a cross reference in the directors' report to the MD&A, provided that: • the cross reference is clear and it is clearly stated that the cross referenced part of the annual report forms part of the directors' report; and • the discussion and analysis in that MD&A is sufficient to meet the minimum content requirements of Schedule 5. The cross reference illustrated here is made with reference to the example statement in Q15/Question A8. The HKICPA's Q&A series on the CO can be found in the HKICPA's website. 12 © 2023 KPMG, a Hong Kong partnership and a member firm of the KPMG global organisation of independent member firms affiliated with KPMG International Limited ("KPMG International"), a private English company limited by guarantee. All rights reserved.

View entire presentation